An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Tenaya Therapeutics (NASDAQ: TNYA) announces participation in two investor conferences focusing on heart disease therapies. Key events include:
H.C. Wainwright Gene Therapy and Gene Editing Conference: March 30, 2022, 7:00 a.m. ET (on demand)
Chardan 6th Annual Genetic Medicines Manufacturing Summit: April 26, 2022, 1:00 p.m. ET
Webcasts for both fireside chats will be accessible on Tenaya’s website for about 30 days post-conference.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced participation in two upcoming investor conferences.
Details of each presentation are as follows:
H.C. Wainwright Gene Therapy and Gene Editing Conference Fireside chat
Date: March 30, 2022 Time: 7:00 a.m. ET – available on demand
Chardan 6th Annual Genetic Medicines Manufacturing Summit
Fireside chat
Date: April 26, 2022 Time: 1:00 p.m. ET
Webcasts of the fireside chats will be available by visiting the Investors section of Tenaya’s website. A replay of each webcast will be available on the Tenaya website for approximately 30 days following each conference.
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.
What events is Tenaya Therapeutics participating in March and April 2022?
Tenaya Therapeutics is participating in the H.C. Wainwright Gene Therapy and Gene Editing Conference on March 30, 2022, and the Chardan 6th Annual Genetic Medicines Manufacturing Summit on April 26, 2022.
What is the stock symbol for Tenaya Therapeutics?
The stock symbol for Tenaya Therapeutics is TNYA.
How can I access the webcasts of Tenaya's investor conference presentations?
Webcasts of Tenaya's presentations will be available on their website for approximately 30 days after each event.
What time is Tenaya's fireside chat at the H.C. Wainwright Conference?
Tenaya's fireside chat at the H.C. Wainwright Conference is scheduled for March 30, 2022, at 7:00 a.m. ET.
What time is Tenaya's fireside chat at the Chardan Summit?
Tenaya's fireside chat at the Chardan 6th Annual Genetic Medicines Manufacturing Summit is on April 26, 2022, at 1:00 p.m. ET.
